Ecovyst FY23 Revenue Outlook $760M – $790M Vs. $842.97M Estimate, Adj. EBITDA $285M – $300M
2023 Financial Outlook
Full year 2023 guidance is as follows:
Sales of $760 million to $790 million1
Sales of $145 million to $155 million for
Citigroup Maintains Neutral on Ecovyst, Lowers Price Target to $10
Citigroup analyst PJ Juvekar maintains Ecovyst (NYSE:ECVT) with a Neutral and lowers the price target from $10.5 to $10.
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers
Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Ecovyst Priced Upsized Secondary Offering of 17,500,000 Shares of Common Stock by Selling Stockholders on Monday at $8.25/Share
Ecovyst Inc. (NYSE: ECVT) (the "Company") today announced the upsize and pricing of the previously announced underwritten public offering (the "Offering") by funds affiliated with CCMP Capital Advisors, LP (the "Selling Stockholders").
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 574 stocks hit new 52-week lows.
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
